Literature DB >> 35353294

C-terminal binding protein 2 promotes high-glucose-triggered cell proliferation, angiogenesis and cellular adhesion of human retinal endothelial cell line.

Han Li1, Feng Zhou1, Xingjian Cao1, Ping Zhao1, Xiaobo Huang2, Wei Xie1, Guowei Zhang3, Xiang Chen4.   

Abstract

PURPOSE: The proliferation and angiogenesis of human retinal endothelial cells (HRECs) are critical for the pathophysiology of diabetic retinopathy (DR). C-terminal binding protein 2 (CtBP2) has multiple biologic functions, but its effect on HRECs under high-glucose (HG) conditions is unclear.
METHODS: The cell viability, angiogenesis, cellular adhesion and CtBP2 expression levels of HRECs were measured following treatment with different concentrations of glucose. Small interfering CtBP2-targeting RNA, wide-type and function mutant plasmid of CtBP2 were constructed and then were transfected into HRECs to evaluate the effects of CtBP2 on cell functions of HRECs.
RESULTS: The expression of CtBP2 in HRECs was increased after HG treatment. HG treatment significantly increased cell proliferation, angiogenesis, and decreased relative gene expressions in gap junctions, tight junctions and adherens junctions. After CtBP2 was inhibited via siRNA, the changes induced by HG were partially restored. Conversely, only wild-type CtBP2 could increase cell proliferation and angiogenesis under HG condition. Mechanistically, we also found that CtBP2 exerted its functions to effect HG-induced changes via Akt signaling pathway.
CONCLUSION: This study implicates that CtBP2 promotes HG-induced cell proliferation, angiogenesis and cellular adhesion, and CtBP2 might be a potential target in the prevention of DR.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Angiogenesis; Cellular adhesion; CtBP2; Diabetic retinopathy; High glucose; Human retinal endothelial cells

Year:  2022        PMID: 35353294     DOI: 10.1007/s10792-022-02283-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  51 in total

Review 1.  Tight junctions and human diseases.

Authors:  Norimasa Sawada; Masaki Murata; Keisuke Kikuchi; Makoto Osanai; Hirotoshi Tobioka; Takashi Kojima; Hideki Chiba
Journal:  Med Electron Microsc       Date:  2003-09

Review 2.  Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved.

Authors:  Maria Lúcia Zaidan Dagli; Francisco Javier Hernandez-Blazquez
Journal:  J Membr Biol       Date:  2007-07-25       Impact factor: 1.843

3.  Suppression of diabetic retinopathy with angiopoietin-1.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Akitaka Tsujikawa; Wenying Qin; Tamim Qaum; Qingwen Xu; Yasufumi Moromizato; Sven-Erik Bursell; Stanley J Wiegand; John Rudge; Ella Ioffe; George D Yancopoulos; Anthony P Adamis
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 4.  Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy.

Authors:  D Ruggiero; M Lecomte; E Michoud; M Lagarde; N Wiernsperger
Journal:  Diabetes Metab       Date:  1997-02       Impact factor: 6.041

Review 5.  Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy.

Authors:  Tapan Behl; Anita Kotwani
Journal:  Pharmacol Res       Date:  2015-06-06       Impact factor: 7.658

Review 6.  Cell-cell communication in diabetic retinopathy.

Authors:  Sayon Roy; Dongjoon Kim; Remington Lim
Journal:  Vision Res       Date:  2017-06-28       Impact factor: 1.886

7.  RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma.

Authors:  Y Zhang; X Jiang; X Qin; D Ye; Z Yi; M Liu; O Bai; W Liu; X Xie; Z Wang; J Fang; Y Chen
Journal:  Oncogene       Date:  2010-07-05       Impact factor: 9.867

8.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

Review 9.  Vascular endothelial growth factor in eye disease.

Authors:  J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal:  Prog Retin Eye Res       Date:  2008-05-28       Impact factor: 21.198

10.  Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition.

Authors:  Hu Huang; Jianbo He; Da'Kuawn Johnson; Yanhong Wei; Ying Liu; Shuang Wang; Gerard A Lutty; Elia J Duh; Richard D Semba
Journal:  Diabetes       Date:  2014-09-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.